Supplementary Material for: Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation [article]

G. Savelli, A. Zaniboni, F. Bertagna, G. Bosio, L. Nisa, C. Rodella, G. Biasiotto, G. Bettinsoli, E. Migliorati, A. Peli
2017 Figshare  
Breast cancer (BC) is the most frequent cancer in European women with nearly 30% of the patients eventually developing metastases. Neuroendocrine differentiation is a rare event, but overexpression of somatostatin receptors in BC has been reported in many studies. Case Report: A patient with liver metastases from BC was treated with peptide receptor radionuclide therapy (PRRT). Computed tomography scan and biochemical examinations showed a clear response to radionuclide therapy. Conclusion:
more » ... py. Conclusion: PRRT may be useful in metastatic BC patients.
doi:10.6084/m9.figshare.5124178.v1 fatcat:q26rovohcfc7zpoth3txeaxepm